| 9721 |
CIPET, Vijayawada
| 6141334
| IS 10124 : Part 1 (2009) |
Fabricated PVC-U Fittings for Potable Water Supplies - Specification Part 1 General Requirements (Second Revision) |
SIZE 20 TO 630MM |
6650 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| 3(Material) |
- |
1100 |
|
FOR PVC RESIN K-Value |
| 5.1 Table-1 Fig.1(Dimension of Socket length) |
- |
500 |
|
NIL |
| 5.1.2 Table-1(Dimensions of mean inside diameter at mid-point of socket depth) |
- |
0 |
|
CHARGES INCLUDED IN DIMENSION |
| 5.1.3 (Out of Roundness Tolerance of Socket Inside Diameter) |
- |
0 |
|
CHARGES INCLUDED IN DIMENSION |
| 5.2 Table-2 Fig.2(Dimensions of socket for elastomeric sealing ring) |
- |
0 |
|
CHARGES INCLUDED IN DIMENSION |
| 6.1(Opacity test in accordance with IS 12235 (Part 3)) |
- |
700 |
|
NIL |
| 6.2(Short Term Hydraulic Test in accordance with Annex A) |
- |
1350 |
|
NIL |
| 8(Marking) |
- |
0 |
|
NIL |
| 6.3(Effect on water test) |
- |
3000 |
|
Nil |
|
06 Jun, 2027 |
-
0.0 |
| 9722 |
CIPET, Vijayawada
| 6141334
| IS 7834 : Part 3 (1987) |
injection moulded PVC socket fittings with solvent cement joints for water supplies: Part 3 Specific requirements for 90 degree elbows |
SIZE 16-315 MM |
3500 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| cl 2.2.2(Dimensions) |
- |
500 |
|
NIL |
| Cl. 2.1 (Ref. Cl. 6.3 of IS 7834 (part 1) : 1987(Effect on water - Lead (first extraction) - Appendix C ) |
- |
3000 |
|
NIL |
| Cl. 2.1 (Ref. Cl. 6.3 of IS 7834 (part 1) : 1987(Effect on water - Lead (third extraction) - Appendix C) |
- |
0 |
|
CHARGES INCLUDED IN LEAD 1ST EXTRACTION |
| Cl. 2.1 (Ref. Cl. 6.3 of IS 7834 (part 1) : 1987(Effect on water - Dialkyl tin C4 and higher homologues measured as tin (third extraction) - Appendix C) |
- |
0 |
|
CHARGES INCLUDED IN LEAD 1ST EXTRACTION |
| Cl. 2.1 (Ref. Cl. 6.3 of IS 7834 (part 1) : 1987(Effect on water - Other toxic substances (third extraction) - Appendix C) |
- |
0 |
|
CHARGES INCLUDED IN LEAD 1ST EXTRACTION |
|
06 Jun, 2027 |
-
Testing charges has been fixed for two years w.e.f. 30-05-2019 to 29-05-2021. |
| 9723 |
CIPET, Vijayawada
| 6141334
| IS 7834 : Part 1 (1987) |
injection moulded PVC socket fittings with solvent cement joints for water supplies: Part 1 General requirements |
SIZE 16-315MM |
6250 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| Cl.4(Minimum Thickness) |
- |
500 |
|
NIL |
| Cl. 5.1.1, 5.1.2, Table 1, Fig 1(Minimum Socket Length) |
- |
0 |
|
CHARGES INCLUDED IN THICKNESS |
| Cl. 5.1.1, 5.1.2, Table 1, Fig 1(Mean Socket Internal Diameter at Mid-Point of Socket Length) |
- |
0 |
|
CHARGES INCLUDED IN THICKNESS |
| Cl. 5.1.1, 5.1.2, Table 1, Fig 1(Out-of-roundness tolerances of socket inside diameter) |
- |
0 |
|
CHARGES INCLUDED IN THICKNESS |
| Cl. 6.1(Stress Relief Test- Appendix A) |
- |
700 |
|
NIL |
| Cl. 6.3(Effect on Water[(Lead ( first extraction )]- Appendix C) |
- |
3000 |
|
NIL |
| Cl. 6.3(Effect on Water[(Lead ( third extraction )]- Appendix C) |
- |
0 |
|
CHARGES INCLUDED IN LEAD 1ST EXTRACTION |
| Cl. 6.3(Effect on Water [Dialkyl tin C4, and higher homologues, measured as tin ( third extraction )]- Appendix C) |
- |
0 |
|
CHARGES INCLUDED IN LEAD 1ST EXTRACTION |
| Cl. 6.3(Effect on Water [Other toxic substances ( third extraction )]- Appendix C) |
- |
0 |
|
CHARGES INCLUDED IN LEAD 1ST EXTRACTION |
| Cl. 6.4(Short-Term Hydraulic Test- Appendix D) |
- |
1350 |
|
NIL |
| Cl. 6.2(Opacity- Appendix B) |
- |
700 |
|
NIL |
|
06 Jun, 2027 |
-
Testing charges has been fixed for two years w.e.f. 30-05-2019 to 29-05-2021. |
| 9724 |
CIPET, Vijayawada
| 6141334
| IS 2508 (2016) |
Polyethylene films and sheets - Specification (Third Revision) |
NATURAL & BLACK COMPOUNDED , TYPE 1 TO 4 |
22675 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| 5.1.1(Appearance) |
- |
500 |
|
NIL |
| 5.1.2(Film Form) |
- |
0 |
|
NIL |
| 5.1.3(Odour) |
- |
0 |
|
NIL |
| 5.1.4(Density, Cl.5 of IS 13360(Part-3/Section-1)) |
- |
700 |
|
NIL |
| 5.1.5(Melt Flow Index. Cl 6, 7 of IS 13360(Part-4/Section-1)) |
- |
1100 |
|
NIL |
| 5.1.6a(Carbon Black Content, Annex-A) |
- |
925 |
|
NIL |
| 5.1.6b(Ash Content, Annex-A) |
- |
1200 |
|
NIL |
| 5.1.6c(Carbon Black Dispersion, Cl.16 of IS 2530) |
- |
700 |
|
NIL |
| 5.2.2(Tolerance on Thickness, Annex-A) |
- |
500 |
|
CHARGE FOR DIMENSION |
| 6.1, Table 1(Tensile strength at break. A) Machine Direction. IS 13360 (Part 5/Sec 1)) |
- |
1800 |
|
NIL |
| 6.1, Table 1(Tensile strength at break. B) Transverse Direction. IS 13360 (Part 5/Sec 3)) |
- |
1300 |
|
NIL |
| 6.1, Table 1(Ageing test at (70-1)c for 7 days , cl 4 IS 7016 ) |
- |
4200 |
|
NIL |
| 6.1, Table 1(Elongation at break ,A) Machine direction .IS 13360(Part-5/sec-1) ) |
- |
0 |
|
CHARGES INCLUDED IN TENSILE STRENGTH |
| 6.1, Table 1(Elongation at break ,B) Cross-machine direction..IS 13360(Part-5/sec-3) ) |
- |
0 |
|
CHARGES INCLUDED IN TENSILE STRENGTH |
| 6.1, Table 1(Dartimpact strength Method B of IS 13360 (Part-5/sec-6) ) |
- |
850 |
|
NIL |
| 6.1, Table 1(Tear resistence. A) Machine direction Annex B) |
- |
1600 |
|
NIL |
| 6.1, Table 1(Tear resistence. B) Transverse direction ) |
- |
1100 |
|
NIL |
| 7.1. Table 2(Tensile strength at break A) Machine direction IS 13360 (Part-5/sec-1) ) |
- |
1300 |
|
NIL |
| 7.1. Table 2(Tensile strength at break,B) Crosse machine direction IS 13360 (Part-5/sec-3) ) |
- |
1300 |
|
NIL |
| 7.1. Table 2(Ageing test at (70-1)c for 7 days , cl 4 IS 7016 ) |
- |
0 |
|
NIL |
| 7.1. Table 2(Elongation at break , A) Machine direction IS 13360 (Part-5/sec-3) IS 13360 (Part-5/sec-1) ) |
- |
0 |
|
CHARGES INCLUDED IN TENSILE STRENGTH |
| 7.1. Table 2(Elongation at break , A) Transverse direction IS 13360 (Part-5/sec-3) ) |
- |
0 |
|
CHARGES INCLUDED IN TENSILE STRENGTH |
| 7.1. Table 2(Dart impact strenght , Method A of IS 3360 (Part-5/sec-6) ) |
- |
0 |
|
NIL |
| 8.1, Table 3(Tensile properties ,A) Yield strenght . IS 3360 (Part-5/sec-1) and IS 3360 (Part-5/sec-3) Test condition- specimen type 5 and test speed 51 mm/min do) |
- |
1800 |
|
NIL |
| 8.1, Table 3(Tensile properties , B) Break strenght . IS 3360 (Part-5/sec-1) and IS 3360 (Part-5/sec-3) Test condition- specimen type 5 and test speed 51 mm/min do) |
- |
1800 |
|
NIL |
| 8.1, Table 3(Tensile properties ,C) Yield elongation . IS 3360 (Part-5/sec-1) and IS 3360 (Part-5/sec-3) Test condition- specimen type 5 and test speed 51 mm/min do) |
- |
0 |
|
CHARGES INCLUDED IN TENSILE STRENGTH |
| 8.1, Table 3(Tensile properties ,D) Break elongation . IS 3360 (Part-5/sec-1) and IS 3360 (Part-5/sec-3) Test condition- specimen type 5 and test speed 51 mm/min do) |
- |
0 |
|
CHARGES INCLUDED IN TENSILE STRENGTH |
| 8.1, Table 3(Tear resistance , Annex B) |
- |
0 |
|
NIL |
| 8.1, Table 3(Puncture resistance , Annex C) |
- |
0 |
|
NIL |
| 9.1, Table 4(Tensile properties ,A) Yield strenght . IS 3360 (Part-5/sec-1) and IS 3360 (Part-5/sec-3) Test condition- specimen type 5 and test speed 51 mm/min do) |
- |
0 |
|
NIL |
| 9.1, Table 4(Tensile properties , B) Break strenght . IS 3360 (Part-5/sec-1) and IS 3360 (Part-5/sec-3) Test condition- specimen type 5 and test speed 51 mm/min do) |
- |
0 |
|
NIL |
| 9.1, Table 4(Tensile properties ,C) Yield elongation . IS 3360 (Part-5/sec-1) and IS 3360 (Part-5/sec-3) Test condition- specimen type 5 and test speed 51 mm/min do) |
- |
0 |
|
CHARGES INCLUDED IN TENSILE STRENGTH |
| 9.1, Table 4(Tensile properties ,D) Break elongation . IS 3360 (Part-5/sec-1) and IS 3360 (Part-5/sec-3) Test condition- specimen type 5 and test speed 51 mm/min do) |
- |
0 |
|
CHARGES INCLUDED IN TENSILE STRENGTH |
| 9.1, Table 4(Tear resistance , Annex B) |
- |
0 |
|
NIL |
| 9.1, Table 4(Puncture resistance , Annex C) |
- |
0 |
|
NIL |
|
06 Jun, 2027 |
-
Included w.e.f. 02.08.2018. Testing charges has been fixed for two years w.e.f. 30-05-2019 to 29-05-2021. |
| 9725 |
CIPET, Vijayawada
| 6141334
| IS 4985 (2021) |
UNPLASTICIZED PVC PIPES FOR POTABLE WATER SUPPLIES SPECIFICATION Fourth Revision |
SIZE: 20MM TO 630MM, CLASS: 1 TO 6 |
27450 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| 11.2(Resistance to External Blows at 0°C) |
- |
1500 |
|
FOR ELASTOMERIC SEALING RING SOCKETS |
| 11.1.1(MECHANICAL PROPERTIES-Hydrostatic Pressure Test (Acceptance Test)-for Plumbing pipes) |
- |
850 |
|
FOR ELASTOMERIC SEALING RING SOCKETS |
| 11.1-Table 7(MECHANICAL PROPERTIES-Hydrostatic Pressure Test (Acceptance Test)-for Integral Sealing Ring
Sockets) |
- |
850 |
|
FOR ELASTOMERIC SEALING RING SOCKETS |
| 11.1-Table 7(MECHANICAL PROPERTIES-Hydrostatic Pressure Test (Type Test)-for Integral Sealing Ring
Sockets) |
- |
11000 |
|
FOR ELASTOMERIC SEALING RING SOCKETS |
| 11.1-Table 6(MECHANICAL PROPERTIES-Hydrostatic Pressure Test (Acceptance Test)) |
- |
850 |
|
FOR ELASTOMERIC SEALING RING SOCKETS |
| 11.1-Table 6(MECHANICAL PROPERTIES-Hydrostatic Pressure Test (Type Test)) |
- |
5000 |
|
FOR ELASTOMERIC SEALING RING SOCKETS |
| 10.6(PHYSICAL AND CHEMICAL CHARACTERISTICS- Density) |
- |
700 |
|
FOR ELASTOMERIC SEALING RING SOCKETS |
| 10.5(PHYSICAL AND CHEMICAL CHARACTERISTICS- Vicat Softening Temperature) |
- |
1100 |
|
FOR ELASTOMERIC SEALING RING SOCKETS |
| 10.4(PHYSICAL AND CHEMICAL CHARACTERISTICS- Reversion Test) |
- |
1200 |
|
FOR ELASTOMERIC SEALING RING SOCKETS |
| 10.2(PHYSICAL AND CHEMICAL CHARACTERISTICS-Opacity) |
- |
700 |
|
FOR ELASTOMERIC SEALING RING SOCKETS |
| 10.1.1(PHYSICAL AND CHEMICAL CHARACTERISTICS-Visual Appearance) |
- |
500 |
|
FOR ELASTOMERIC SEALING RING SOCKETS |
| 9.1(PIPE ENDS) |
- |
500 |
|
FOR ELASTOMERIC SEALING RING SOCKETS
CHARGE IS INCLUDED IN VISUAL APPEARANCE |
| 7.2.1.2-Table 4(DIMENSIONS-Sockets for elastomeric sealing ring joints-Socket inner Diameter) |
- |
500 |
|
FOR ELASTOMERIC SEALING RING SOCKETS |
| 7.2.1.2(a)-Table 5(DIMENSIONS-Sockets for elastomeric sealing ring joints-Minimum depth of engagement) |
- |
500 |
|
FOR ELASTOMERIC SEALING RING SOCKETS
RS. 500 INCLUDES ALL DIMENSIONAL PARAMETERS |
| 7.2.1.1-Table 3(DIMENSIONS-Socket-Sockets for solvent cement jointing-Diameter at mid point of the socket length (Maximum)) |
- |
0 |
|
FOR ELASTOMERIC SEALING RING SOCKETS
RS. 500 INCLUDES ALL DIMENSIONAL PARAMETERS |
| 7.2.1.1-Table 3(DIMENSIONS-Socket-Sockets for solvent cement jointing-Diameter at mid point of the socket length (Minimum)) |
- |
0 |
|
FOR ELASTOMERIC SEALING RING SOCKETS
RS. 500 INCLUDES ALL DIMENSIONAL PARAMETERS |
| 7.2.1.1-Table 3(DIMENSIONS-Socket-Sockets for solvent cement jointing-Minimum Length) |
- |
0 |
|
FOR ELASTOMERIC SEALING RING SOCKETS
RS. 500 INCLUDES ALL DIMENSIONAL PARAMETERS |
| 7.1.2.1(DIMENSIONS-PIPE-Thickness(Maximum)) |
- |
0 |
|
FOR ELASTOMERIC SEALING RING SOCKETS
RS. 500 INCLUDES ALL DIMENSIONAL PARAMETERS |
| 7.1.2.1(DIMENSIONS-PIPE-Thickness(Minimum)) |
- |
0 |
|
FOR ELASTOMERIC SEALING RING SOCKETS
RS. 500 INCLUDES ALL DIMENSIONAL PARAMETERS |
| 7.1.1.2(DIMENSIONS-PIPE-Ovality (Maximum)) |
- |
500 |
|
FOR ELASTOMERIC SEALING RING SOCKETS
RS. 500 INCLUDES ALL DIMENSIONAL PARAMETERS |
| 7.1.1.2(DIMENSIONS-PIPE-O.D. at any Point (Maximum)) |
- |
0 |
|
FOR ELASTOMERIC SEALING RING SOCKETS
RS. 500 INCLUDES ALL DIMENSIONAL PARAMETERS |
| 7.1.1.2(DIMENSIONS-PIPE-O.D. at any Point (Minimum)) |
- |
0 |
|
FOR ELASTOMERIC SEALING RING SOCKETS
RS. 500 INCLUDES ALL DIMENSIONAL PARAMETERS |
| 7.1.1.1(DIMENSIONS-PIPE-Mean O.D. (Mamimum)) |
- |
0 |
|
FOR ELASTOMERIC SEALING RING SOCKETS
RS. 500 INCLUDES ALL DIMENSIONAL PARAMETERS |
| 7.1.1.1(DIMENSIONS-PIPE-Mean O.D. (Minimum)) |
- |
0 |
|
FOR ELASTOMERIC SEALING RING SOCKETS
RS. 500 INCLUDES ALL DIMENSIONAL PARAMETERS |
| Clause 10.7(Sulphated Ash Content) |
- |
1200 |
|
FOR ELASTOMERIC SEALING RING SOCKETS |
| 11.2(Resistance to External Blows at 0°C) |
- |
0 |
|
Resistance to External Blows at 0°C |
| 11.1-Table 6(MECHANICAL PROPERTIES-Hydrostatic Pressure Test (Acceptance Test)) |
- |
0 |
|
MECHANICAL PROPERTIES-Hydrostatic Pressure Test (Acceptance Test) |
| 11.1-Table 7(MECHANICAL PROPERTIES-Hydrostatic Pressure Test (Acceptance Test)-for Integral Sealing Ring Sockets) |
- |
0 |
|
MECHANICAL PROPERTIES-Hydrostatic Pressure Test (Acceptance Test)-for Integral Sealing Ring Sockets |
| 11.1-Table 6(MECHANICAL PROPERTIES-Hydrostatic Pressure Test (Type Test)) |
- |
0 |
|
MECHANICAL PROPERTIES-Hydrostatic Pressure Test (Type Test) |
| 11.1-Table 7(MECHANICAL PROPERTIES-Hydrostatic Pressure Test (Type Test)-for Integral Sealing Ring Sockets) |
- |
0 |
|
MECHANICAL PROPERTIES-Hydrostatic Pressure Test (Type Test) |
| 10.1.1(PHYSICAL AND CHEMICAL CHARACTERISTICS-Visual Appearance) |
- |
0 |
|
PHYSICAL AND CHEMICAL CHARACTERISTICS-Visual Appearance |
| 10.5(PHYSICAL AND CHEMICAL CHARACTERISTICS- Vicat Softening Temperature) |
- |
0 |
|
Vicat Softening Temperature |
| 10.4(PHYSICAL AND CHEMICAL CHARACTERISTICS- Reversion Test) |
- |
0 |
|
Reversion Test |
| 10.2(PHYSICAL AND CHEMICAL CHARACTERISTICS-Opacity) |
- |
0 |
|
Opacity |
| 10.1(PHYSICAL AND CHEMICAL CHARACTERISTICS-Visual Appearance) |
- |
0 |
|
Visual Appearance |
| 9.1(PIPE ENDS) |
- |
0 |
|
PIPE ENDS |
| 7.2.1.2(a)-Table 5(DIMENSIONS-Sockets for elastomeric sealing ring joints-Minimum depth of engagement) |
- |
0 |
|
Minimum depth of engagement |
| 7.2.1.1-Table 3(DIMENSIONS-Socket-Sockets for solvent cement jointing-Minimum Length) |
- |
0 |
|
Minimum Length |
| 7.2.1.1-Table 3(DIMENSIONS-Socket-Sockets for solvent cement jointing-Diameter at mid point of the socket length (Minimum)) |
- |
0 |
|
Diameter at mid point of the socket length (Minimum) |
| 7.1.2.1(DIMENSIONS-PIPE-Thickness(Minimum)) |
- |
0 |
|
PIPE-Thickness(Minimum) |
| 7.1.2.1(DIMENSIONS-PIPE-Thickness(Maximum)) |
- |
0 |
|
-PIPE-Thickness(Maximum) |
| 7.1.1.2(DIMENSIONS-PIPE-Ovality (Maximum)) |
- |
0 |
|
Ovality (Maximum) |
| 7.1.1.2(DIMENSIONS-PIPE-O.D. at any Point (Minimum)) |
- |
0 |
|
O.D. at any Point (Minimum) |
| 7.1.1.2(DIMENSIONS-PIPE-O.D. at any Point (Maximum)) |
- |
0 |
|
O.D. at any Point (Maximum) |
| 7.1.1.1(DIMENSIONS-PIPE-Mean O.D. (Minimum)) |
- |
0 |
|
Mean O.D. (Minimum) |
| 7.1.1.1(DIMENSIONS-PIPE-Mean O.D. (Mamimum)) |
- |
0 |
|
Mean O.D. (Mamimum) |
| 10.7(Sulphated Ash Content) |
- |
0 |
|
Sulphated Ash Content |
| 10.1(Colour) |
- |
0 |
|
Colour |
| 6.1.2(PVC Resin) |
- |
0 |
|
Nil |
|
06 Jun, 2027 |
-
REVISED VERSION OF IS 4985:2021 INCLUDED W.E.F. 4-8-2021.. |
| 9726 |
CIPET, Vijayawada
| 6141334
| IS 4984 (2016) |
Polyethylene pipes for water supply - Specification (Fifth Revision) |
SDR 41 to 6, DN 16 to 1200 mm, PE 63/80/100, PN 2 to20 |
55650 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| 8.10(Slow Crack Growth Rate) |
- |
6000 |
|
INCLUDES SPECIMEN CHARGE |
| 8.9 table-6(Elongation at Break) |
- |
1800 |
|
INCLUDES SPECIMEN CHARGE |
| 8.8(Tensile Strength for Butt-fusion) |
- |
1800 |
|
INCLUDES SPECIMEN CHARGE |
| 8.7(Density) |
- |
700 |
|
NIL |
| 8.5Â (Oxidation Induction Time) |
- |
2200 |
|
NIL |
| 8.4(Â Â Melt Flow Rate) |
- |
1100 |
|
NIL |
| 8.2(Longitudinal Reversion Test) |
- |
1200 |
|
INCLUDES SPECIMEN CHARGE |
| 8.1.2 table -5(Internal Pressure Creep Rupture Test of Pipe Joints) |
- |
1600 |
|
NIL |
| 8,/8.1/8.1.1 table-5(PERFORMANCE REQUIREMENTS / Hydraulic Characteristics/ Internal Pressure Creep Rupture Test of Pipe) |
- |
21900 |
|
INCLUDES ALL TESTS |
| 7.4.1.2(Ovality) |
- |
0 |
|
INCLUDES IN DIMENSION |
| Cl-7.4(Mean Outside Diameter (For upto 50 mm take 8 reading, above 50mm take 6 reading & average will be reported)) |
- |
500 |
|
INCLUDES ALL DIMENSIONAL MEASUREMENTS |
| 7.2(Length) |
- |
0 |
|
INCLUDES IN DIMENSION |
| 6.2.1(6.1.1Â Â Â Identification Stripes) |
- |
500 |
|
NIL |
| 8.6(Overall migration) |
- |
2200 |
|
INCLUDES SPECIMEN CHARGES |
| 8.3(Carbon black) |
- |
1625 |
|
INCLUDES CARBON BLACK DISPERSION TEST |
| 5.3(e)(Carbon Black Master Batch) |
- |
5450 |
|
INCLUDES ALL TEST FOR CARBON BLACK POWDER |
| 5.3(d)(Carbon Black Master Batch) |
- |
950 |
|
NIL |
| 5.3(c)(Carbon Black Master Batch) |
- |
925 |
|
NIL |
| 5.2(Polyethylene Resin) |
- |
5200 |
|
INCLUDES ALL TEST CHARGES FOR RAW MATERIAL |
|
06 Jun, 2027 |
-
EVISED VERSION INCLUDED OF IS 4984:2016. |
| 9727 |
Bee Pharmo Labs Pvt. Ltd., Thane
| 7139416
| IS 17782 (2021) |
FORTIFIED RICE KERNELS-SPECIFICATION |
- |
32900 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| 4.1(Description) |
- |
200 |
|
-- |
| 4.1.1(length, breadth, and thickness) |
- |
600 |
|
-- |
| 4.1.2(length, breadth, thickness, thousand kernel weight, and true density) |
- |
700 |
|
-- |
| 4.1.6(ree from added colouring matter, metal peices and other impurities) |
- |
400 |
|
-- |
| 4.3(Pesticides/insecticides residues, poisonous metals, naturally occurring toxic substances and other contaminant Aflatoxins) |
- |
12500 |
|
Pesticides, Metal contaminants, Melamine, Aflatoxins |
| Table-1, (4.1.3, 4.1.5 and 8)(i) Iron, mg/100 g) |
- |
500 |
|
-- |
| Table-1, (4.1.3, 4.1.5 and 8)(ii) Folic acid, μg/100 g) |
- |
1500 |
|
-- |
| Table-1, (4.1.3, 4.1.5 and 8)(iii) Vitamin B12, μg/100 g) |
- |
1500 |
|
-- |
| Table-2, 4.1.4, 4.1.5 and 8(i) Zinc, mg/100 g) |
- |
500 |
|
-- |
| Table-2, 4.1.4, 4.1.5 and 8(ii) Vitamin A, μg/100 g) |
- |
1000 |
|
-- |
| Table-2, 4.1.4, 4.1.5 and 8(iii) Thiamine) |
- |
1000 |
|
-- |
| Table-2, 4.1.4, 4.1.5 and 8(iv) Riboflavin (Vitamin B2), mg/100 g) |
- |
1000 |
|
-- |
| Table-2, 4.1.4, 4.1.5 and 8(v) Niacin (Vitamin B3), mg/100 g) |
- |
1000 |
|
-- |
| Table-2, 4.1.4, 4.1.5 and 8(vi) Pyridoxine (Vitamin B6), mg/100 g) |
- |
1500 |
|
-- |
| Table-3, 4.1.6 and 8(i) Moisture content,) |
- |
350 |
|
-- |
| Table-3, 4.1.6 and 8(ii) Broken fortified rice kernels,) |
- |
200 |
|
-- |
| Table-3, 4.1.6 and 8(iii) Foreign matter,) |
- |
200 |
|
-- |
| Table-3, 4.1.6 and 8(iv) Damaged grains) |
- |
200 |
|
-- |
| Table-3, 4.1.6 and 8(v) Discolored grains) |
- |
200 |
|
-- |
| Table-3, 4.1.6 and 8(vi) Chalky grains) |
- |
200 |
|
-- |
| Table-3, 4.1.6 and 8(vii) Admixture) |
- |
200 |
|
-- |
| 4.5.1(Percent solid loss) |
- |
500 |
|
-- |
| 4.5.2(Cooking time) |
- |
1000 |
|
-- |
| 4.5.4(iron, folic acid, vitamin B12) |
- |
4000 |
|
-- |
| Table-4, 4.7 and 8(i) Total plate count,) |
- |
650 |
|
-- |
| Table-4, 4.7 and 8(ii) Yeasts and moulds,) |
- |
650 |
|
-- |
| Table-4, 4.7 and 8(iii) Coliform count,) |
- |
650 |
|
-- |
|
15 Mar, 2027 |
-
Exclusion: Cl.4.5.3 (Texture of the cooked fortified rice) |
| 9728 |
Bee Pharmo Labs Pvt. Ltd., Thane
| 7139416
| IS 17780 (2021) |
FORTIFIED RICE-SPECIFICATION |
- |
26050 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| 4.1(Description) |
- |
200 |
|
-- |
| 4.1.1(blend of fortified rice kernels and polished raw Rice ratio) |
- |
500 |
|
-- |
| 4.1.5(5 Fortified rice shall be free from added colouring
matter, foreign matter, metal pieces, mold, weevils,
obnoxious substances, discolouration, poisonous seeds,
rodent hair, excreta) |
- |
400 |
|
-- |
| 4.2(Pesticides/insecticides residues, poisonous
metals, naturally occurring toxic substances and other
contaminants (if any) in fortified rice shall not exceed
the limit as prescribed in the Food Safety and Standards
(Contaminants, Toxins and Residues) Regulations,
2011) |
- |
11500 |
|
Pesticides, Metal Contaminants, Melamine |
| 4.1.2 4.1.5 and 8.1(i) Moisture content, percent by mass, Max) |
- |
350 |
|
-- |
| 4.1.2 4.1.5 and 8.1(Foreign matter1)
(a) Inorganic, percent by mass, Max) |
- |
200 |
|
-- |
| 4.1.2 4.1.5 and 8.1(Foreign matter1)
(b) Organic, percent by mass, Max) |
- |
200 |
|
-- |
| 4.1.2 4.1.5 and 8.1(iii) Weevilled kernels, percent by mass, Max) |
- |
200 |
|
-- |
| 4.1.2 4.1.5 and 8.1(iv) Heat – Damaged Kernels , percent by mass, Max) |
- |
200 |
|
-- |
| 4.1.2 4.1.5 and 8.1(v) Damaged Kernels, percent by mass, Max) |
- |
200 |
|
-- |
| 4.1.2 4.1.5 and 8.1(vi) Kernels with pin point, percent by mass, Max) |
- |
200 |
|
-- |
| 4.1.2 4.1.5 and 8.1(vii) Immature Kernels, percent by mass, Max) |
- |
200 |
|
-- |
| 4.1.2 4.1.5 and 8.1(viii) Chalky Kernels, percent by mass, Max) |
- |
200 |
|
-- |
| 4.1.2 4.1.5 and 8.1(ix) Uric acid, mg/kg, Max) |
- |
800 |
|
-- |
| 4.1.2 4.1.5 and 8.1(x) Aflatoxin B1, µg/kg, Max) |
- |
1000 |
|
-- |
| 4.1.3 and 8.1(i) Iron, mg/kg) |
- |
500 |
|
-- |
| 4.1.3 and 8.1(ii) Folic acid, µg/kg) |
- |
1500 |
|
-- |
| 4.1.3 and 8.1(iii) Vitamin B12, µg/kg) |
- |
1500 |
|
-- |
| 4.4 and 8.1(i) Zinc, mg/kg) |
- |
500 |
|
-- |
| 4.4 and 8.1(ii) Vitamin A, µg/kg) |
- |
1000 |
|
-- |
| 4.4 and 8.1(iv) Thiamine (vitamin B1), mg/kg) |
- |
1000 |
|
-- |
| 4.4 and 8.1(v) Riboflavin (vitamin B2), mg/kg) |
- |
1000 |
|
-- |
| 4.4 and 8.1(vi) Niacin (vitamin B3), mg/kg) |
- |
1000 |
|
-- |
| 4.4 and 8.1(vii) Pyridoxine (vitamin B6), mg/kg) |
- |
1500 |
|
-- |
| 4.1.4(Fortified rice kernels shall be uniformly distributed
in fortified rice.) |
- |
200 |
|
-- |
|
15 Mar, 2027 |
-
- |
| 9729 |
Bee Pharmo Labs Pvt. Ltd., Thane
| 7139416
| IS 1155 (2022) |
ATTA - SPECIFICATION(THIRD REVISION OF IS 1155) |
- |
15000 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| 4.1(Description- IS 1155) |
- |
200 |
|
- |
| 4.2(Microscopic Appearance -IS 1155) |
- |
200 |
|
- |
| 4.4,Table 1 (i)(Moisture - IS 1155) |
- |
350 |
|
- |
| 4.4,Table 1 (ii)(Total Ash (On dry basis ) - IS 1155) |
- |
350 |
|
- |
| 4.4,Table 1 (iii)("Acid Insoluble Ash (On Dry basis) - IS 1155
") |
- |
350 |
|
- |
| 4.4,Table 1 (iv)(Gluten (On dry basis) - IS 1155) |
- |
350 |
|
- |
| 4.4,Table 1 (v)(Crude Fibre (On dry basis) - IS 1155) |
- |
400 |
|
- |
| 4.4,Table 1 (vi)(Alcoholic Acidity (as H2SO4 ) in 90 % alcohol - IS 1155) |
- |
350 |
|
- |
| 4.4,Table 1 (vii)(Granularity - IS 1155) |
- |
200 |
|
- |
| 4.4,Table 1 (viii)(Uric acid - IS 1155) |
- |
350 |
|
- |
| 4.6(2,4-Dichlorophenoxy Acetic acid) |
- |
5400 |
|
All pesticide residues |
| 4.6(Azoxystrobin) |
- |
0 |
|
- |
| 4.6(Sum of benomyl & carbendazim expressed as carbendazim)) |
- |
0 |
|
- |
| 4.6(carbendazim) |
- |
0 |
|
- |
| 4.6(Bitertanol) |
- |
0 |
|
- |
| 4.6(Carbaryl) |
- |
0 |
|
- |
| 4.6(Carbofuran (sum of carbofuran & 3-hydroxy carbofuran expressedas carbofuran)) |
- |
0 |
|
- |
| 4.6(Carfentrazone ethyl) |
- |
0 |
|
- |
| 4.6(Chlorimuron ethyl) |
- |
0 |
|
- |
| 4.6(Chlorpyriphos) |
- |
0 |
|
- |
| 4.6(Clodinafop-propargyl) |
- |
0 |
|
- |
| 4.6(Cypermethrin (sum of isomers) (Fat soluble residue)) |
- |
0 |
|
- |
| 4.6(Deltamethrin (Decamethrin)) |
- |
0 |
|
- |
| 4.6(Dichlorvos (DDVP) (content of dichloroacetaldehyde (D.C.A.)) |
- |
0 |
|
- |
| 4.6(Diclofop (sum diclofop-methyl & diclofop acid expressed as diclofop-methyl)) |
- |
0 |
|
- |
| 4.6(Difenoconazole) |
- |
0 |
|
- |
| 4.6(Dithiocarbamates(the residue tolerance limit are determined and expressed as mg/CS2/kg and refer separately to the residues arising from any or each group of dithiocarbamates)) |
- |
0 |
|
- |
| 4.6(Epoxyconazole) |
- |
0 |
|
- |
| 4.6(Ethion (Residues to be determined as ethion & its oxygen analogue and expressed as ethion)) |
- |
0 |
|
- |
| 4.6(Fenoxaprop-p-ethyl) |
- |
0 |
|
- |
| 4.6(Fipronil) |
- |
0 |
|
- |
| 4.6(Iodosulfuron Methyl Sodium) |
- |
0 |
|
- |
| 4.6(Isoproturon) |
- |
0 |
|
- |
| 4.6(Kresoxim Methyl) |
- |
0 |
|
- |
| 4.6(Malathion (Malathion to be determined & expressed as combined residues of malathion and malaoxon)) |
- |
0 |
|
- |
| 4.6(Mesosulfuron Methyl) |
- |
0 |
|
- |
| 4.6(Methabenzthiazuron) |
- |
0 |
|
- |
| 4.6(Methyl Chlorophenoxy Acetic Acid (MCPA)) |
- |
0 |
|
- |
| 4.6(Metribuzin) |
- |
0 |
|
- |
| 4.6(Metsulfuron Methyl) |
- |
0 |
|
- |
| 4.6(Monocrotophos) |
- |
0 |
|
- |
| 4.6(Oxydemeton-Methyl) |
- |
0 |
|
- |
| 4.6(Paraquat dichloride (Determined as Paraquatcations)) |
- |
0 |
|
- |
| 4.6(Pendimethalin) |
- |
0 |
|
- |
| 4.6(Phenthoate) |
- |
0 |
|
- |
| 4.6(Phorate (sum of Phorates,its oxygen analogue and their sulphoxides & sulphones,expressed as phorate)) |
- |
0 |
|
- |
| 4.6(Picoxystrobin) |
- |
0 |
|
- |
| 4.6(Pinoxaden) |
- |
0 |
|
- |
| 4.6(Primiphos-methyl) |
- |
0 |
|
- |
| 4.6(Propiconazole) |
- |
0 |
|
- |
| 4.6(Pyraclostrobin) |
- |
0 |
|
- |
| 4.6(Sulfosulfuron) |
- |
0 |
|
- |
| 4.6(Thiomethoxam) |
- |
0 |
|
- |
| 4.6(Thiometon (Residues determined as thiometon its sulfoxide & sulphone expressed as thiometon)) |
- |
0 |
|
- |
| 4.6(Thiophanate-Methyl) |
- |
0 |
|
- |
| 4.6(Trichlorfon) |
- |
0 |
|
- |
| 4.6(Triadimefon) |
- |
0 |
|
- |
| 4.6(Trifloxystrobin) |
- |
0 |
|
- |
| 4.6(Triallate) |
- |
0 |
|
- |
| 4.6(Triasulfuron) |
- |
0 |
|
- |
| 4.6(Tridemorph) |
- |
0 |
|
- |
| 4.6(Trifluralin) |
- |
0 |
|
- |
| 4.6(Lead) |
- |
500 |
|
- |
| 4.6(Copper) |
- |
500 |
|
- |
| 4.6(Arsenic) |
- |
500 |
|
- |
| 4.6(Tin) |
- |
500 |
|
- |
| 4.6(Cadmium) |
- |
500 |
|
- |
| 4.6(Mercury) |
- |
500 |
|
- |
| 4.6(Methyl Mercury (Calculated as the element)) |
- |
500 |
|
- |
| 4.6(Total Aflatoxins) |
- |
1000 |
|
- |
| 4.6(Aflatoxin B1) |
- |
0 |
|
- |
| 4.6(Ochratoxin A) |
- |
1000 |
|
- |
| 4.6(Deoxynivalenol) |
- |
1000 |
|
- |
| 4.2(Microscopic Appearance -IS 1155) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.4,Table 1 (i)(Moisture - IS 1155) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.4,Table 1 (v)(Crude Fibre (On dry basis) - IS 1155) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.4,Table 1 (vii)(Granularity - IS 1155) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.4,Table 1 (viii)(Uric acid - IS 1155) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(carbendazim) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Carbofuran (sum of carbofuran & 3-hydroxy carbofuran expressedas carbofuran)) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Carfentrazone ethyl) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Chlorimuron ethyl) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Clodinafop-propargyl) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Cypermethrin (sum of isomers) (Fat soluble residue)) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Deltamethrin (Decamethrin)) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Dichlorvos (DDVP) (content of dichloroacetaldehyde (D.C.A.)) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Diclofop (sum diclofop-methyl & diclofop acid expressed as diclofop-methyl)) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Difenoconazole) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Dithiocarbamates(the residue tolerance limit are determined and expressed as mg/CS2/kg and refer separately to the residues arising from any or each group of dithiocarbamates)) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Epoxyconazole) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Ethion (Residues to be determined as ethion & its oxygen analogue and expressed as ethion)) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Fenoxaprop-p-ethyl) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Fipronil) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Iodosulfuron Methyl Sodium) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Isoproturon) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Kresoxim Methyl) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Malathion (Malathion to be determined & expressed as combined residues of malathion and malaoxon)) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Mesosulfuron Methyl) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Methabenzthiazuron) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Methyl Chlorophenoxy Acetic Acid (MCPA)) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Metribuzin) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Metsulfuron Methyl) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Monocrotophos) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Oxydemeton-Methyl) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Paraquat dichloride (Determined as Paraquatcations)) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Pendimethalin) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Phenthoate) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Phorate (sum of Phorates,its oxygen analogue and their sulphoxides & sulphones,expressed as phorate)) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Picoxystrobin) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Pinoxaden) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Primiphos-methyl) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Propiconazole) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Pyraclostrobin) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Sulfosulfuron) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Tebuconazole) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Thiomethoxam) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Thiometon (Residues determined as thiometon its sulfoxide & sulphone expressed as thiometon)) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Thiophanate-Methyl) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Trichlorfon) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Triadimefon) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Trifloxystrobin) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Triallate) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Triasulfuron) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Tridemorph) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Trifluralin) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Lead) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Copper) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Arsenic) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Tin) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Cadmium) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Mercury) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Methyl Mercury (Calculated as the element)) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Total Aflatoxins) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Aflatoxin B1) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Ochratoxin A) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Deoxynivalenol) |
- |
0 |
|
Duplication of parameter in LIMS |
| 4.6(Tebuconazole) |
- |
0 |
|
Duplication of parameter in LIMS |
|
15 Mar, 2027 |
-
- |
| 9730 |
Bee Pharmo Labs Pvt. Ltd., Thane
| 7139416
| IS 14309 (1995) |
Blended edible vegetable oils specification |
- |
2500 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| Table-1(Moisture and volatile matter percent by mass, Max type1) |
- |
550 |
|
- |
| Table-1(Acid value, mx type 1) |
- |
550 |
|
- |
| Table-1(Unsaponifiable matter, percent by mass, MaX type1) |
- |
850 |
|
- |
| Table-1(Flash point, Pen&y-Martens type1) |
- |
550 |
|
- |
| Table-1(Moisture and volatile matter percent by mass, Max type2) |
- |
550 |
|
- |
| Table-1(Acid value, mx type2) |
- |
550 |
|
- |
| Table-1(Unsaponifiable matter, percent by mass, MaX type2) |
- |
850 |
|
- |
| Table-1(Flash point, Pen&y-Martens ,type 2) |
- |
550 |
|
- |
| Table-1(Moisture and volatile matter percent by mass, Max type 3) |
- |
550 |
|
- |
| Table-1(Acid value, mx type 3) |
- |
550 |
|
- |
| Table-1(Unsaponifiable matter, percent by mass, MaX type3) |
- |
850 |
|
- |
| Table-1(Flash point, Pen&y-Martens type3 ) |
- |
550 |
|
- |
|
15 Mar, 2027 |
-
- |
| 9731 |
Bee Pharmo Labs Pvt. Ltd., Thane
| 7139416
| IS 2400 (2022) |
BESAN - SPECIFICATION (SECOND REVISION OF IS 2400) |
- |
10000 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| 4.1(Description) |
- |
100 |
|
- |
| 4.2(Detection for presence of Lathyrus sativus in besan - Annex A) |
- |
100 |
|
- |
| 4.2("Detection of Metanil yellow in besan -
Annex B") |
- |
100 |
|
- |
| 4.3(Sieve size - IS 460 (Part 1)) |
- |
200 |
|
- |
| 4.4(Microscopic Appearance) |
- |
200 |
|
- |
| 4.7(Pesticides/insecticides residues, toxic metals, naturally occurring toxic substances and other contaminants (if any)) |
- |
6700 |
|
- |
| "Table 1 Sl No. i"(Moisture - Annex A of IS 1009) |
- |
350 |
|
- |
| "Table 1 Sl No. ii"("Total ash (on dry basis) -
Annex B of IS 1009") |
- |
350 |
|
- |
| "Table 1 Sl No. iii"("Acid insoluble ash (on dry basis) -
Annex C of IS 1009") |
- |
350 |
|
- |
| "Table 1 Sl No. v"(Crude protein (on dry basis) - IS 7219) |
- |
350 |
|
- |
| "Table 1 Sl No. vi"(Uric acid (on dry basis) - IS 4333 (Part 5)) |
- |
350 |
|
- |
| "Table 1 Sl No. vii"("Crude fibre, (on dry basis) -
Annex D of IS 1158") |
- |
500 |
|
- |
|
15 Mar, 2027 |
-
- |
| 9732 |
Bee Pharmo Labs Pvt. Ltd., Thane
| 7139416
| IS 4884 (2021) |
STERILIZED / UHT STERILIZED CREAM – SPECIFICATION |
- |
2050 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| Clause 4.2(Appearance-IS 4884) |
- |
100 |
|
- |
| Clause 4.3(Odour & Flavour-IS 4884) |
- |
100 |
|
- |
| Clause 4.4(Body & Texture-IS 4884) |
- |
150 |
|
- |
| Table 1 (Clause 4.7) (i)(Fat-IS 3509) |
- |
350 |
|
- |
| Table 1 (Clause 4.7)(ii)(Titratable acidity-IS 3509) |
- |
350 |
|
- |
| Table 1 (Clause 4.7)(iii)(Incubation test-IS 4884) |
- |
1000 |
|
- |
|
15 Mar, 2027 |
-
- |
| 9733 |
Bee Pharmo Labs Pvt. Ltd., Thane
| 7139416
| IS 1656 (2022) |
MILK-CEREAL BASED COMPLEMENTARY FOODS SPECIFICATION (Fifth Revision of IS 1656) |
- |
30000 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| Clause 4.5,Table 1 ,Sl No i)(Pantothenic acid) |
- |
1500 |
|
-- |
| Clause 4.5,Table 1 ,Sl No ii)(Vitamin B12) |
- |
1500 |
|
-- |
| Clause 4.5,Table 1 ,Sl No vi)(Calcium) |
- |
350 |
|
-- |
| Clause 4.5,Table 1 ,Sl No vii)(Phophorus) |
- |
700 |
|
-- |
| Clause 4.5,Table 1 ,Sl No viii)(Chloride) |
- |
350 |
|
-- |
| Clause 4.5,Table 1 ,Sl No ix)(Magnesium) |
- |
350 |
|
-- |
| Clause 4.5,Table 1 ,Sl No x)(Sodium) |
- |
500 |
|
-- |
| Clause 4.5,Table 1 ,Sl No xi)(Selenium) |
- |
500 |
|
-- |
| Clause 4.5,Table 1 ,Sl No xvi)(Iodine) |
- |
700 |
|
-- |
| Clause 4.5,Table 1 ,Sl No xvii)(Potassium) |
- |
500 |
|
-- |
| Clause 4.5,Table 1 ,Sl No xviii)(Pyridoxine) |
- |
1500 |
|
-- |
| Clause 4.5,Table 1 ,Sl No xv)(Biotine) |
- |
1500 |
|
-- |
| Clause 4.8,Table 2 ,Sl No i)(Moisture) |
- |
350 |
|
-- |
| Clause 4.8,Table 2 ,Sl No ii)(Protein, a)Total protein including milk protein (N x 6.25)) |
- |
350 |
|
-- |
| Clause 4.8,Table 2 ,Sl No ii)(b)Milk protein (N x 6.38)) |
- |
350 |
|
-- |
| Clause 4.8,Table 2 ,Sl No iii)(Fat, a)Total fat including milk fat) |
- |
350 |
|
-- |
| Clause 4.8,Table 2 ,Sl No iii)(b)Milk fat) |
- |
350 |
|
-- |
| Clause 4.8,Table 2 ,Sl No iv)(Total cabohydrates) |
- |
350 |
|
-- |
| Clause 4.8,Table 2 ,Sl No v)(Total ash) |
- |
350 |
|
-- |
| Clause 4.8,Table 2 ,Sl No vi)(Acid insoluble ash in dilute hydrochloric acid) |
- |
350 |
|
-- |
| Clause 4.8,Table 2 ,Sl No viii)(Vitamin C) |
- |
700 |
|
-- |
| Clause 4.8,Table 2 ,Sl No ix)(Iron) |
- |
500 |
|
-- |
| Clause 4.8,Table 2 ,Sl No x)(Crude fibre (on dry basis)) |
- |
500 |
|
-- |
| Clause 4.8,Table 2 ,Sl No xi)(Vitamin D) |
- |
1500 |
|
-- |
| Clause 4.8,Table 2 ,Sl No xii)(Thiamine) |
- |
1000 |
|
-- |
| Clause 4.8,Table 2 ,Sl No xiii)(Riboflavin) |
- |
1000 |
|
-- |
| Clause 4.8,Table 2 ,Sl No xiv)(Niacin equivalent) |
- |
750 |
|
-- |
| Clause 4.8,Table 2 ,Sl No xv)(Dietary fibre equivalent (DFE)2)) |
- |
1500 |
|
-- |
| Clause 4.8,Table 2 ,Sl No xvi)(Zinc) |
- |
500 |
|
-- |
| Clause 4.11,Table 4 ,Sl No i)(Lead) |
- |
500 |
|
-- |
| Clause 4.11,Table 4 ,Sl No ii)(Copper) |
- |
500 |
|
-- |
| Clause 4.11,Table 4 ,Sl No iii)(Arsenic) |
- |
500 |
|
-- |
| Clause 4.11,Table 4 ,Sl No iv)(Tin) |
- |
500 |
|
-- |
| CClause 4.11,Table 4 ,Sl No v)(Cadmium) |
- |
500 |
|
-- |
| Clause 4.11,Table 4 ,Sl No vi)(Melamine) |
- |
1500 |
|
-- |
| Clause 4.8,Table 3, Sl No i)(Aerobic plate count) |
- |
500 |
|
-- |
| Clause 4.8,Table 3, ,Sl No ii)(Coliform count) |
- |
500 |
|
-- |
| Clause 4.8,Table 3, ,Sl No iii)(Staphylococcus aureus (Coagulase positive)) |
- |
500 |
|
-- |
| Clause 4.8,Table 3, ,Sl No iv)(yeast and mould count) |
- |
500 |
|
-- |
| Clause 4.8,Table 3, ,Sl No v)(Salmonella sp.) |
- |
500 |
|
-- |
| Clause 4.8,Table 3, ,Sl No vi)(Listeria monocytogenes) |
- |
500 |
|
-- |
| Clause 4.8,Table 3, ,Sl No vii)(Bacillus cereus) |
- |
500 |
|
-- |
| Clause 4.8,Table 3, ,Sl No viii)(Sulphitr reducing clostridia) |
- |
500 |
|
-- |
| Clause 4.8,Table 3, ,Sl No ix)(E. coli) |
- |
500 |
|
-- |
| 4.1(Description - IS 1656) |
- |
200 |
|
-- |
| 4.2(Free from scorched particles - IS 1656) |
- |
300 |
|
-- |
| Clause 4.8,Table 2 ,Sl No vii)(Vitamin A (as retinol equivalent RE)) |
- |
1000 |
|
-- |
|
15 Mar, 2027 |
-
- |
| 9734 |
Bee Pharmo Labs Pvt. Ltd., Thane
| 7139416
| IS 9584 (2022) |
CHEESE POWDER - SPECIFICATION (First Revision of IS 9584) |
- |
4000 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| 4.1(Description) |
- |
50 |
|
- |
| 4.2(Flavour) |
- |
50 |
|
- |
| 4.6 Table 1 (i)(Milk Fat (On dry basis)) |
- |
325 |
|
- |
| 4.6 Table 1 (ii)(Moisture - IS 11623 for referene purpose and IS 16072 for routine purpose) |
- |
325 |
|
- |
| 4.6 Table 1 (iii)(Salt (added Sodium Chloride)) |
- |
325 |
|
- |
| 4.6 Table:2(i)(Aerobic Plate count - IS 5402(P-1)) |
- |
325 |
|
- |
| 4.6 Table:2(ii)(Coliform count - IS 5401(P-1)) |
- |
325 |
|
- |
| 4.6Table:2(iii)(S.aureus - IS 5887(P-8/Sec-1):2002) |
- |
325 |
|
- |
| 4.6Table:2(iv)(Yeast & Mould count - IS 5403:1999) |
- |
325 |
|
- |
| 4.6 Table:2(v)(Salmonella sp.- IS 5887(P-3/Sec-1):2020) |
- |
325 |
|
- |
| 4.6 Table:2(vi)(L.monocytogenes - IS 14988(P-1):2020) |
- |
325 |
|
- |
| 4.6 Table:2(vii)(B.cereus - IS 5887(P-6):2012) |
- |
325 |
|
- |
| 4.6 Table:2(viii)(Sulphite reducing clostridia - ISO 15213:2003) |
- |
325 |
|
- |
| 4.6 Table:2(ix)(E.coli- IS 5887(P-1):1976) |
- |
325 |
|
- |
|
15 Mar, 2027 |
-
- |
| 9735 |
Bee Pharmo Labs Pvt. Ltd., Thane
| 7139416
| IS 5550 (2023) |
BURFI � SPECIFICATION (First Revision of IS 5550) |
- |
3500 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| 5.1(Body and Texture-IS 5550:2023) |
- |
50 |
|
- |
| 5.2(Colour and Flavour-IS 5550:2023) |
- |
50 |
|
- |
| 5.3 Table-1(i)(Moisture -IS 10484) |
- |
300 |
|
- |
| 5.3 Table-1(ii)(Milk fat-IS 12758) |
- |
300 |
|
- |
| 5.3 Table-1(iii)(Total reducing Sugars(including lactose)-IS 1479 (Part II)) |
- |
300 |
|
- |
| 5.3 Table-1(iv)(Sucrose-IS 4079) |
- |
200 |
|
- |
| 5.3 Table-1(v)(Acidity-IS 4883) |
- |
200 |
|
- |
| 5.3 Table-1(i)(Moisture -IS 10484) |
- |
300 |
|
- |
| 5.3 Table-1(ii)(Milk fat-IS 12758) |
- |
300 |
|
- |
| 5.3 Table-1(iii)(Total reducing Sugars(including lactose)-IS 1479) |
- |
300 |
|
- |
| 5.3 Table -1(iv)(Sucrose-IS 4079) |
- |
200 |
|
- |
| 5.3 Table-1(v)(Acidity-IS 4883) |
- |
200 |
|
- |
| 5.3 Table:2(i)(Aerobic Plate count - IS 5402(P-1 or P-2)) |
- |
300 |
|
- |
| 5.6 Table:2(ii)(Coliform count - IS 5401(P-1)) |
- |
300 |
|
- |
| 5.6 Table:2(iii)(S.aureus - IS 5887(P-8/Sec-1):2002) |
- |
300 |
|
- |
| 5.6 Table:2(iv)(Yeast & Mould count.- IS 16069(p-1)) |
- |
300 |
|
- |
| 5.6 Table:2(v)(E.coli- IS 5887(P-1):1976) |
- |
300 |
|
- |
| 5.6 Table:2(vi)(Salmonella sp. - IS 5887(P-3/Sec-1):2020) |
- |
300 |
|
- |
| 5.6 Table:2(vii)(L.monocytogenes - IS 14988(P-1):2020) |
- |
300 |
|
- |
|
15 Mar, 2027 |
-
- |
| 9736 |
Bee Pharmo Labs Pvt. Ltd., Thane
| 7139416
| IS 7839 (2022) |
DRIED ICE CREAM MIX - SPECIFICATION (First Revision of IS 7839) |
- |
5000 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| 3.2(Description) |
- |
125 |
|
- |
| 3.5 Table 1 (i)(Moisture - IS 11623 / 16072) |
- |
325 |
|
- |
| 3.5 Table 1 (ii)(Milk Fat - IS 11721 OR 12249 ( part 2)) |
- |
325 |
|
- |
| 3.5 Table 1 (iii)(Sucrose -Annex c of IS 2802 or 11764) |
- |
325 |
|
- |
| 3.5 Table 1 (iv)(Titratable acidity (as lactic acid) IS 11765) |
- |
325 |
|
- |
| 3.5 Table 1 (v)(Solubility index IS 12759) |
- |
325 |
|
- |
| 3.5 Table 1 (vi)(Milk Proteins IS 11917) |
- |
325 |
|
- |
| 3.5 Table:2(i)(Aerobic Plate count - IS 5402(P-1)) |
- |
325 |
|
- |
| 3.5 Table:2(ii)(Coliform count - IS 5401(P-1)) |
- |
325 |
|
- |
| 3.5Table:2(iii)(S.aureus - IS 5887(P-8/Sec-1):2002) |
- |
325 |
|
- |
| 3.5Table:2(iv)(Yeast & Mould count - IS 5403:1999) |
- |
325 |
|
- |
| 3.5 Table:2(v)(Salmonella sp.- IS 5887(P-3/Sec-1):2020) |
- |
325 |
|
- |
| 3.5 Table:2(vi)(L.monocytogenes - IS 14988(P-1):2020) |
- |
325 |
|
- |
| 3.5 Table:2(vii)(B.cereus - IS 5887(P-6):2012) |
- |
325 |
|
- |
| 3.5 Table:2(viii)(Sulphite reducing clostridia - ISO 15213:2003) |
- |
325 |
|
- |
| 3.5 Table:2(ix)(E.coli- IS 5887(P-1):1976) |
- |
325 |
|
- |
|
15 Mar, 2027 |
-
- |
| 9737 |
Bee Pharmo Labs Pvt. Ltd., Thane
| 7139416
| IS 2785 (2022) |
CHEESE - SPECIFICATION (Second Revision of IS 2785) |
- |
5000 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| 5.2.1(Appearance - IS 2785 :2022) |
- |
100 |
|
- |
| 5.2.2(Odour and Flavour-IS 2785 :2022) |
- |
100 |
|
- |
| 5.2.3(Texture and Consistency) |
- |
100 |
|
- |
| 3 and 5.3 Table 1 (i) (a) Hard Pressed Cheese(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (a) Hard Pressed Cheese(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (b) Semi Hard Chesse(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (b) Semi Hard Chesse(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) © Semi Soft chesse(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) © Semi Soft chesse(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (d) Soft Chesse(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (d) Soft Chesse(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (d) Extra hard Cheese(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (d) Extra hard Cheese(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (a) Cheddar(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (a) Cheddar(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (b) Danbo(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (b) Danbo(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) © Edam(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) © Edam(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (d)Gouda(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (d)Gouda(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (e) Harvati(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (e) Harvati(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (e) Harvati 30 percent(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (e) Harvati 30 percent(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (e) Harvati 60 percent(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (e) Harvati 60 percent(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (f) Tilsiter(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (f) Tilsiter(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (f) Tilsiter 30 percent(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (f) Tilsiter 30 percent(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (f) Tilsiter 60 percent(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (f) Tilsiter 60 percent(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (g) Cottage cheese and creamed cottage cheese(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (g) Cottage cheese and creamed cottage cheese(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (h) Cream cheese(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (h) Cream cheese(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (j) Coulommiers(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (j) Coulommiers(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (k) Camembert 30 percent(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (k) Camembert 30 percent(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (k) Camembert 40 percent(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (k) Camembert 40 percent(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (k) Camembert 45 percent(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (k) Camembert 45 percent(%) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (k) Camembert 55 percent(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (k) Camembert 55 percent(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (m) Brie(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (m) Brie(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (n) Saint Paulin(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (n) Saint Paulin(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (p) Samsoe(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (p) Samsoe(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (p) Samsoe 30percent(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (p) Samsoe 30percent(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (q) Emmentaler(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (q) Emmentaler(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) ® Provolone Smoked(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) ® Provolone Smoked(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) ® Provolone Umsmoked(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (r|)Provolone Umsmoked(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (s) Extra hard grating cheese(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (s) Extra hard grating cheese(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (t) Mozzarella Cheese(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (t) Mozzarella Cheese(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (u) Pizza Cheese(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (i) (u) Pizza Cheese(Milk fat (On dry basis) IS 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (iii) (a) Processed Cheese(a) Moisture IS- 2785-2022 (Processed cheeze when sold in package othen than tin)) |
- |
350 |
|
- |
| 4 and 5.3 Table 1 (iii) (a) Processed Cheese(b) Moisture IS- 2785-2022 (Processed cheeze in chiplets, packed sliced)) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (iii) (a) Processed Cheese(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (iii) (b) Processed Cheese Spread(Moisture IS- 2785-2022) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (iii) (b) Processed Cheese Spread(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (iv) (a) Creamed whey chesses(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (iv) (b) Whey Cheese(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (iv) (c) Skimmed whey chesse(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (a) Soft Cheese in brine(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 3 and 5.3 Table 1 (b) Semi-hard cheese in brine(Milk fat (On dry basis) IS 12758-2005) |
- |
350 |
|
- |
| 5.4 Table 2-i(Coliform-IS 5401(P-1):2012) |
- |
350 |
|
- |
| 5.4 Table 2-ii(S.aureus-IS 5887(P-8/Sec-1):2002) |
- |
350 |
|
- |
| 5.4 Table 2-iii(Yeast & Mould count-IS 5403:1999) |
- |
350 |
|
- |
| 5.4 Table 2-iv(E.coli-IS 5887(P-1):1976) |
- |
350 |
|
- |
| 5.4 Table 2-v(Salmonella spp.-IS 5887(P-3/Sec-1):2020) |
- |
350 |
|
- |
| 5.4 Table 2-vi(L.monocytogenes-IS 14988(P-1):2020) |
- |
350 |
|
- |
| 5.5 Table 3-i(Aerobic Colony count - IS 5402 (Part 2)) |
- |
350 |
|
- |
| 5.5 Table 3-ii(Coliform-IS 5401(P-1):2012) |
- |
350 |
|
- |
| 5.5 Table 3-iii(S.aureus-IS 5887(P-8/Sec-1):2002) |
- |
350 |
|
- |
| 5.5 Table 3-iv(E.coli-IS 5887(P-1):1976) |
- |
350 |
|
- |
| 5.5 Table 3-v(Salmonella spp.-IS 5887(P-3/Sec-1):2020) |
- |
350 |
|
- |
| 5.5 Table 3-vi(L.monocytogenes-IS 14988(P-1):2020) |
- |
350 |
|
- |
|
15 Mar, 2027 |
-
- |
| 9738 |
Bee Pharmo Labs Pvt. Ltd., Thane
| 7139416
| IS 1806 (2018) |
Malted milk foods - Specification (Second Revision) |
- |
6500 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| 4.3-Table 1- i(Moisture) |
- |
350 |
|
- |
| 4.3-Table 1- ii(Total protein (N × 6.25) (on dry basis),) |
- |
400 |
|
- |
| 4.3-Table 1- iii(Total fat (on dry basis)) |
- |
400 |
|
- |
| 4.3-Table 1- iv(Total ash (on dry basis)) |
- |
400 |
|
- |
| 4.3-Table 1- v(Acid insoluble ash (on dry basis) (in dilute HCl)) |
- |
400 |
|
- |
| 4.3-Table 1- vi(Solubility) |
- |
350 |
|
- |
| 4.3-Table 1- viii(Test for starch) |
- |
200 |
|
- |
| 4.3-Table 1- ix(Bacterial count) |
- |
400 |
|
- |
| 4.3-Table 1- x(Coliform count) |
- |
400 |
|
- |
| 4.3-Table 1- xi(E. coli) |
- |
400 |
|
- |
| 4.3-Table 1- xii(Yeast and mould count) |
- |
400 |
|
- |
| 4.3-Table 1- xiii(Salmonella) |
- |
400 |
|
- |
| 4.3-Table 1- xiv(Shigella) |
- |
400 |
|
- |
| 4.3-Table 1- xv(Vibrio cholerae ) |
- |
400 |
|
- |
| 4.3-Table 1- xv( V. parahaemolyticus) |
- |
400 |
|
- |
| 4.3-Table 1- xvi(Faecal streptococci ) |
- |
400 |
|
- |
| 4.3-Table 1- xvi( Staphylococcusaureas) |
- |
400 |
|
- |
|
15 Mar, 2027 |
-
- |
| 9739 |
Bee Pharmo Labs Pvt. Ltd., Thane
| 7139416
| IS 1010 (1968) |
Specification for suji or rava (Semolina) (First Revision) |
- |
2150 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| 3.1(Description) |
- |
100 |
|
- |
| 3.2(Particle Size) |
- |
250 |
|
- |
| 3.3(Microscopic Appearance) |
- |
100 |
|
- |
| 3.4 i(Moisture) |
- |
350 |
|
- |
| 3.4 ii(Total ash (on dry basis)) |
- |
350 |
|
- |
| 3.4 iii(Acid insoluble ash (on dry basis)) |
- |
350 |
|
- |
| 3.4 iv(Gluten (on dry basis)) |
- |
300 |
|
- |
| 3.4 v(Alcoholic acidity (as Hâ‚‚SOâ‚„) in 90% alcohol) |
- |
350 |
|
- |
|
15 Mar, 2027 |
-
- |
| 9740 |
Bee Pharmo Labs Pvt. Ltd., Thane
| 7139416
| IS 1009 (1979) |
Specification for maida for General Purposes (Second Revision) |
- |
2500 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| Clause 3.1(Description) |
- |
100 |
|
- |
| Clause 3.2(Microscopic Apperance) |
- |
50 |
|
- |
| Clause 3.3 Table 1(Moisture) |
- |
350 |
|
- |
| Clause 3.3 Table 1(Total Ash) |
- |
350 |
|
- |
| Clause 3.3 Table 1(Acid Insoluble ash) |
- |
350 |
|
- |
| Clause 3.3 Table 1(Gluten) |
- |
300 |
|
- |
| Clause 3.3 Table 1(Alcoholic acidity) |
- |
350 |
|
- |
| Clause 3.3 Table 2(Granularity) |
- |
300 |
|
- |
| Clause 3.3 Table 3(Uric acid) |
- |
350 |
|
- |
|
15 Mar, 2027 |
-
- |
| 9741 |
Bee Pharmo Labs Pvt. Ltd., Thane
| 7139416
| IS 10484 (2021) |
Paneer - Specification |
- |
5000 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| Clause 5 (5.1)(Colour & appearance-IS 10484) |
- |
50 |
|
- |
| Clause 5 (5.3)(Body & Texture-IS 10484) |
- |
50 |
|
- |
| Table 1Clause 5.6 (i)(Moisture-IS 10484) |
- |
350 |
|
- |
| Table 1Clause 5.6 (ii)(Milk Fat(ODB)-IS 10484) |
- |
350 |
|
- |
| Table 1Clause 5.6 (iii)(Titratable acidity (as lactic acid)-IS 10484) |
- |
300 |
|
- |
| Table 1Clause 5.6 (iv)(Protein (ODB)-IS 11917) |
- |
350 |
|
- |
| Table 1Clause 5.6 (v)(Ash (ODB)-IS 10484) |
- |
350 |
|
- |
| Table 2 Clause 5.6 (i)(Aerobic plate count-Doc No.FAD 15 (02815) (Requirement limit specified for m class based on 2- Class sampling plan)) |
- |
450 |
|
- |
| Table 2 Clause 5.6 (ii)(Coliform count- IS 5401 (Part 1) (Requirement limit specified for m class based on 2- Class sampling plan)) |
- |
450 |
|
- |
| Table 2 Clause 5.6 (iii)(Staphylococcuus aureus- ( coagulase positive) IS 5887 (Part 2) (Requirement limit specified for m class based on 2- Class sampling plan)) |
- |
450 |
|
- |
| Table 2 Clause 5.6 (iv)(Yeast & mould- IS 5403 (Requirement limit specified for m class based on 2- Class sampling plan)) |
- |
450 |
|
- |
| Table 2 Clause 5.6 (v)(Escherichia Coli- IS 5887 (Part 1) (Requirement limit specified for m class based on 2- Class sampling plan)) |
- |
450 |
|
- |
| Table 2 Clause 5.6 (vi)(Salmonella sp.- IS 5887 (Part 3) (Requirement limit specified for m class based on 2- Class sampling plan)) |
- |
450 |
|
- |
| Table 2 Clause 5.6 (vii)(Listeria monocytogenes- IS 14988 (Part 1) (Requirement limit specified for m class based on 2- Class sampling plan)) |
- |
450 |
|
- |
| Clause 5 (5.2)(Flavour-IS 10484) |
- |
50 |
|
- |
|
15 Mar, 2027 |
-
- |
| 9742 |
Bee Pharmo Labs Pvt. Ltd., Thane
| 7139416
| IS 12299 (2021) |
DAIRY WHITENER - SPECIFICATION First Revision |
- |
9000 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| Table 2 /clause no 6.4 SI.No.i)(E.coli) |
- |
500 |
|
- |
| Table 2 /clause no 6.4 SI.No.i)(Sulphite reducing clostridia) |
- |
500 |
|
- |
| Table 2 /clause no 6.4 SI.No.i)(Bacillus cereus) |
- |
500 |
|
- |
| Table 2 /clause no 6.4 SI.No.i)(Listeria monocytogenes) |
- |
500 |
|
- |
| Table 2 /clause no 6.4 SI.No.i)(Salmonella spp.) |
- |
500 |
|
- |
| Table 2 /clause no 6.4 SI.No.i)(Yeast & Mould count) |
- |
500 |
|
- |
| Table 2 /clause no 6.4 SI.No.i)(S.aureus) |
- |
500 |
|
- |
| Table 2 /clause no 6.4 SI.No.i)( coliform count) |
- |
500 |
|
- |
| Table 2 /clause no 6.4 SI.No.i)(Aerobic Plate count) |
- |
500 |
|
- |
| Table 6.4/clause no(viii)(Titrable acidity) |
- |
350 |
|
- |
| Table 6.4/clause no(vi)(Acid insoluble ash) |
- |
400 |
|
- |
| Table 6.4/clause no(v)(Total ash ) |
- |
500 |
|
- |
| Table 6.4/clause no(iv)(Insolubility index) |
- |
400 |
|
- |
| Table 6.4/clause no(iii)(Milk protein) |
- |
400 |
|
- |
| Table 6.4/clause no(vii)(Total added sugar) |
- |
600 |
|
- |
| Table 6.4/clause no(ii)( Milk fat) |
- |
400 |
|
- |
| Table 6.4/clause no(i)( Moisture) |
- |
400 |
|
- |
| 6.1(Extraneous matter and added colours) |
- |
200 |
|
- |
| 6.2(Orthophosphoric acid and polyphosphoric acid) |
- |
400 |
|
- |
| 6.4, Table 1, (ix)(Scorched Particle) |
- |
450 |
|
- |
|
15 Mar, 2027 |
-
- |
| 9743 |
Bee Pharmo Labs Pvt. Ltd., Thane
| 7139416
| IS 1166 (2022) |
SWEETENED CONDENSED MILK, SWEETENED CONDENSED PARTLY SKIMMED MILK, SWEETENED CONDENSED SKIMMED MILK AND SWEETENED CONDENSD HIGH FAT MILK- SPECIFICATION (Third Revision of IS 1166) |
- |
13500 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| ( Clauses 4.1 and 4.7) Tabel 1 (i)(Total milk solid) |
- |
300 |
|
-- |
| ( Clauses 4.1 and 4.7) Tabel 1 (ii)(Milk Fat) |
- |
350 |
|
-- |
| ( Clauses 4.1 and 4.7) Tabel 1 (iii)(Milk solid not fat) |
- |
350 |
|
-- |
| ( Clauses 4.1 and 4.7) Tabel 1 (iv)(Milk protien in milk solis not fat) |
- |
350 |
|
-- |
| ( Clauses 4.1 and 4.7) Tabel 1 (v)(Accelerated storage test) |
- |
400 |
|
-- |
| (Clause 4.7) Tabel 2 (i)(Aerobic plate count) |
- |
400 |
|
-- |
| (Clause 4.7) Tabel 2 (ii)(Coliform count) |
- |
400 |
|
-- |
| (Clause 4.7) Tabel 2 (iii)(Staphylococcus Aureus (Coagulates positive)) |
- |
400 |
|
-- |
| (Clause 4.7) Tabel 2 (iv)(Yeast and mould count) |
- |
400 |
|
-- |
| (Clause 4.7) Tabel 2 (v)(Salmonella) |
- |
400 |
|
-- |
| (Clause 4.7) Tabel 2 (vi)(Listeria monocytogens) |
- |
400 |
|
-- |
| (Clause 4.7) Tabel 2 (vii)(E Coli) |
- |
400 |
|
-- |
| (Clause 4.6)(Measurement of size and count of lactose crystals) |
- |
200 |
|
-- |
| ( Clause 4.9 ) Tabel 3 (i)(Lead) |
- |
400 |
|
-- |
| ( Clause 4.9 ) Tabel 3 (ii)(Arsenic) |
- |
400 |
|
-- |
| ( Clause 4.9 ) Tabel 3 (iii)(Aflatoxin M1) |
- |
1300 |
|
-- |
| ( Clause 4.9 ) Tabel 3 (iv)(Melamine) |
- |
1300 |
|
-- |
| 4.2(Taste , Flavour,Colour & Odour. Free from rancid , fruity , moldy , tallowy , cooked , sour, sandy and any other objectionable odour and taste -IS 1166) |
- |
250 |
|
-- |
| 4.8(Ethion (Residues to be determined as ethion & its oxygen analogue and expressed as ethion)) |
- |
5100 |
|
-- |
| 4.8(Ethofenprox (Etofenprox)) |
- |
0 |
|
-- |
| 4.8(Fenpropathrin) |
- |
0 |
|
-- |
| 4.8(Fenvalerate (fat soluble residue)) |
- |
0 |
|
-- |
| 4.8(Fipronil) |
- |
0 |
|
-- |
| 4.8(Flubendiamide) |
- |
0 |
|
-- |
| 4.8(Flusilazole) |
- |
0 |
|
-- |
| 4.8(Glufosinate Ammonium) |
- |
0 |
|
-- |
| 4.8(Imidacloprid) |
- |
0 |
|
-- |
| 4.8(Indoxacarb) |
- |
0 |
|
-- |
| 4.8(Kresoxim Methyl) |
- |
0 |
|
-- |
| 4.8(Methomyl) |
- |
0 |
|
-- |
| 4.8(Metolachlor) |
- |
0 |
|
-- |
| 4.8(Monocrotophos) |
- |
0 |
|
-- |
| 4.8(Oxydemeton-Methyl) |
- |
0 |
|
-- |
| 4.8(Paraquat dichloride (Determined as Paraquatcations)) |
- |
0 |
|
-- |
| 4.8(Penconazole) |
- |
0 |
|
-- |
| 4.8(Phenthoate) |
- |
0 |
|
-- |
| 4.8(Phorate (sum of phorate,its oxygen analogue and their sulphoxides & sulphones, expressed as Phorate)) |
- |
0 |
|
-- |
| 4.8(Pirimiphos-methyl) |
- |
0 |
|
-- |
| 4.8(Propiconazole) |
- |
0 |
|
-- |
| 4.8(Pyraclostrobin) |
- |
0 |
|
-- |
| 4.8(Tebuconazole) |
- |
0 |
|
-- |
| 4.8(Thiacloprid) |
- |
0 |
|
-- |
| 4.8(Thiophanate-Methyl) |
- |
0 |
|
-- |
| 4.8(Thiamethoxam) |
- |
0 |
|
-- |
| 4.8(Triacontanol) |
- |
0 |
|
-- |
| 4.8(Triadimefon) |
- |
0 |
|
-- |
| 4.8(Trichlorfon) |
- |
0 |
|
-- |
| 4.8(Ampicillin) |
- |
0 |
|
-- |
| 4.8(Apramycin) |
- |
0 |
|
-- |
| 4.8(Albendazole) |
- |
0 |
|
-- |
| 4.8(Chlotetracycline/Oxytetracycline/Tetracycline) |
- |
0 |
|
-- |
| 4.8(Ceftiofur) |
- |
0 |
|
-- |
| 4.8(Cefphactril) |
- |
0 |
|
-- |
| 4.8(Doramectin) |
- |
0 |
|
-- |
| 4.8(Diminazene) |
- |
0 |
|
-- |
| 4.8(Flunixin) |
- |
0 |
|
-- |
| 4.8(Febantel/Fenbendazole/Oxyfendazole) |
- |
0 |
|
-- |
| 4.8(Ivermectin) |
- |
0 |
|
-- |
| 4.8(Lincomycin) |
- |
0 |
|
-- |
| 4.8(Monensin) |
- |
0 |
|
-- |
| 4.8(Meloxicam) |
- |
0 |
|
-- |
| 4.8(Neomycin) |
- |
0 |
|
-- |
| 4.8(Oxyclozanide) |
- |
0 |
|
-- |
| 4.8(Parbendazole) |
- |
0 |
|
-- |
| 4.8(2,4-Dichlorophenoxy Acetic acid) |
- |
0 |
|
-- |
| 4.8(Acephate (expressed as mixture of Methamidophos and acephate)) |
- |
0 |
|
-- |
| 4.8(Acetamiprid) |
- |
0 |
|
-- |
| 4.8(Azoxystrobin) |
- |
0 |
|
-- |
| 4.8(Sum of benomyl & carbendazim expressed as carbendazim)) |
- |
0 |
|
-- |
| 4.8(Bifenthrin) |
- |
0 |
|
-- |
| 4.8(Bitertanol) |
- |
0 |
|
-- |
| 4.8(Buprofezin) |
- |
0 |
|
-- |
| 4.8(Carbaryl) |
- |
0 |
|
-- |
| 4.8(Carbendazim) |
- |
0 |
|
-- |
| 4.8(Carbofuran (sum of carbofuran & 3-hydroxy carbofuran expressedas carbofuran)) |
- |
0 |
|
-- |
| 4.8(Chlorantraniliprole) |
- |
0 |
|
-- |
| 4.8(Chlorpyriphos) |
- |
0 |
|
-- |
| 4.8(Chlothianidin (Chlothianidin & its metabolite Thiazolymethylguanidine(TMG) ,Thiazolymethylurea(TZMU),Methylnitroguanidine(MNG)) |
- |
0 |
|
-- |
| 4.8(Cypermethrin (sum of isomers) (Fat soluble residue)) |
- |
0 |
|
-- |
| 4.8(Deltamethrin (Decamethrin)) |
- |
0 |
|
-- |
| 4.8(Dichlorvos (DDVP) (content of dichloroacetaldehyde (D.C.A.)) |
- |
0 |
|
-- |
| 4.8(Difenoconazole) |
- |
0 |
|
-- |
| 4.8(Dimethoate) |
- |
0 |
|
-- |
| 4.8(Dinotefuron) |
- |
0 |
|
-- |
| 4.8(Mancozeb) |
- |
0 |
|
-- |
| 4.8(metiram as CS2) |
- |
0 |
|
-- |
| 4.8(Edifenphos) |
- |
0 |
|
-- |
| 4.8(Emamectin Benzoate) |
- |
0 |
|
-- |
| 4.8(Spectinomycin) |
- |
0 |
|
-- |
| 4.8(Sulfadiazine) |
- |
0 |
|
-- |
| 4.8(Sulfanilamide) |
- |
0 |
|
-- |
| 4.8(Sulfa Chloropyrazine) |
- |
0 |
|
-- |
| 4.8(Thiabendazole) |
- |
0 |
|
-- |
| 4.8(Trimethoprim) |
- |
0 |
|
-- |
| 4.8(Tylosin) |
- |
0 |
|
-- |
| 4.8(Virginiamycin) |
- |
0 |
|
-- |
| 4.8(Chlorothalonil) |
- |
0 |
|
-- |
| 4.8(Sulfaquinoxaline) |
- |
0 |
|
-- |
| 4.8(Sulfadimidine) |
- |
0 |
|
-- |
|
15 Mar, 2027 |
-
- |
| 9744 |
Bee Pharmo Labs Pvt. Ltd., Thane
| 7139416
| IS 1165 (2022) |
WHOLE MILK POWDER - SPECIFICATION (Sixth Revision of IS 1165) |
- |
15000 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| Clause 3.5,Table 1 ,Sl No i)(Moisture) |
- |
350 |
|
-- |
| Clause 3.5,Table 1 ,Sl No ii)(Total solids) |
- |
150 |
|
-- |
| Clause 3.5,Table 1 ,Sl No iii)(Milk fat) |
- |
350 |
|
-- |
| Clause 3.5,Table 1 ,Sl No iv)(Milk protein in milk solids not fat) |
- |
350 |
|
-- |
| Clause 3.5,Table 1 ,Sl No v)(Insolubility index) |
- |
350 |
|
-- |
| Clause 3.5,Table 1 ,Sl No vi)(Total ash(on dry basis)) |
- |
350 |
|
-- |
| Clause 3.5,Table 1 ,Sl No vii)(Titratable acidity (lactic acid),) |
- |
350 |
|
-- |
| Clause 3.5,Table 1 ,Sl No viii)(Scorched particle) |
- |
300 |
|
-- |
| Clause 3.5,Table 2 ,Sl No i)(Aerobic plate count) |
- |
400 |
|
-- |
| Clause 3.5,Table 2 ,Sl No ii)(Coliform Count) |
- |
400 |
|
-- |
| Clause 3.5,Table 2 ,Sl No iii)(Staphylococcus aureus(Coagulase positive)) |
- |
400 |
|
-- |
| Clause 3.5,Table 2 ,Sl No iv)(Yeast and mould count) |
- |
400 |
|
-- |
| Clause 3.5,Table 2 ,Sl No v)(Salmonella sp) |
- |
400 |
|
-- |
| Clause 3.5,Table 2 ,Sl No vi)(Listeria monocytogenes) |
- |
400 |
|
-- |
| Clause 3.5,Table 2 ,Sl No vii)(Bacillus cereus) |
- |
400 |
|
-- |
| Clause 3.5,Table 2 ,Sl No viii)(Sulphite reducing clostridia) |
- |
400 |
|
-- |
| Clause 3.5,Table 2 ,Sl No ix)(E. coli) |
- |
400 |
|
-- |
| Clause 3.7,Table 3, Sl No i)(Lead) |
- |
450 |
|
-- |
| Clause 3.7,Table 3 ,Sl No ii)(Arsenic) |
- |
450 |
|
-- |
| Clause 3.7,Table 3,Sl No iii)(Aflaoxin) |
- |
1300 |
|
-- |
| Clause 3.7,Table 3, Sl No iv)(Melamine) |
- |
1300 |
|
-- |
| 3.1(Discription) |
- |
50 |
|
-- |
| 3.2(Flavour and Taste) |
- |
100 |
|
-- |
| 3.3(extraneous matter) |
- |
100 |
|
-- |
| 3.6(2,4-Dichlorophenoxy Acetic acid) |
- |
5100 |
|
Pesticide Residues & Antibiotic Residues |
| 3.6(Acephate (expressed as mixture of Methamidophos and acephate)) |
- |
0 |
|
-- |
| 3.6(Acetamiprid) |
- |
0 |
|
-- |
| 3.6(Azoxystrobin) |
- |
0 |
|
-- |
| 3.6(Sum of benomyl & carbendazim expressed as carbendazim)) |
- |
0 |
|
-- |
| 3.6(Bifenthrin) |
- |
0 |
|
-- |
| 3.6(Bitertanol) |
- |
0 |
|
-- |
| 3.6(Buprofezin) |
- |
0 |
|
-- |
| 3.6(Carbaryl) |
- |
0 |
|
-- |
| 3.6(Carbendazim) |
- |
0 |
|
-- |
| 3.6(Carbofuran (sum of carbofuran & 3-hydroxy carbofuran expressedas carbofuran)) |
- |
0 |
|
-- |
| 3.6(Chlorantraniliprole) |
- |
0 |
|
-- |
| 3.6(Chlorothalonil) |
- |
0 |
|
-- |
| 3.6(Chlorpyriphos) |
- |
0 |
|
-- |
| 3.6(Chlothianidin (Chlothianidin & its metabolite Thiazolymethylguanidine(TMG) ,Thiazolymethylurea(TZMU),Methylnitroguanidine(MNG)) |
- |
0 |
|
-- |
| 3.6(Cypermethrin (sum of isomers) (Fat soluble residue)) |
- |
0 |
|
-- |
| 3.6(Deltamethrin (Decamethrin)) |
- |
0 |
|
-- |
| 3.6(Dichlorvos (DDVP) (content of dichloroacetaldehyde (D.C.A.)) |
- |
0 |
|
-- |
| 3.6(Difenoconazole) |
- |
0 |
|
-- |
| 3.6(Dimethoate) |
- |
0 |
|
-- |
| 3.6(Dinotefuron) |
- |
0 |
|
-- |
| 3.6(Mancozeb) |
- |
0 |
|
-- |
| 3.6(metiram as CS2) |
- |
0 |
|
-- |
| 3.6(Edifenphos) |
- |
0 |
|
-- |
| 3.6(Emamectin Benzoate) |
- |
0 |
|
-- |
| 3.6(Ethion (Residues to be determined as ethion & its oxygen analogue and expressed as ethion)) |
- |
0 |
|
-- |
| 3.6(Ethofenprox (Etofenprox)) |
- |
0 |
|
-- |
| 3.6(Fenpropathrin) |
- |
0 |
|
-- |
| 3.6(Fenvalerate (fat soluble residue)) |
- |
0 |
|
-- |
| 3.6(Fipronil) |
- |
0 |
|
-- |
| 3.6(Flubendiamide) |
- |
0 |
|
-- |
| 3.6(Flusilazole) |
- |
0 |
|
-- |
| 3.6(Glufosinate Ammonium) |
- |
0 |
|
-- |
| 3.6(Imidacloprid) |
- |
0 |
|
-- |
| 3.6(Indoxacarb) |
- |
0 |
|
-- |
| 3.6(Kresoxim Methyl) |
- |
0 |
|
-- |
| 3.6(Methomyl) |
- |
0 |
|
-- |
| 3.6(Methyl Chlorophenoxy Acetic Acid (MCPA)) |
- |
0 |
|
-- |
| 3.6(Metolachlor) |
- |
0 |
|
-- |
| 3.6(Monocrotophos) |
- |
0 |
|
-- |
| 3.6(Oxydemeton-Methyl) |
- |
0 |
|
-- |
| 3.6(Paraquat dichloride (Determined as Paraquatcations)) |
- |
0 |
|
-- |
| 3.6(Penconazole) |
- |
0 |
|
-- |
| 3.6(Phenthoate) |
- |
0 |
|
-- |
| 3.6(Phorate (sum of phorate,its oxygen analogue and their sulphoxides & sulphones, expressed as Phorate)) |
- |
0 |
|
-- |
| 3.6(Pirimiphos-methyl) |
- |
0 |
|
-- |
| 3.6(Propiconazole) |
- |
0 |
|
-- |
| 3.6(Pyraclostrobin) |
- |
0 |
|
-- |
| 3.6(Tebuconazole) |
- |
0 |
|
-- |
| 3.6(Thiacloprid) |
- |
0 |
|
-- |
| 3.6(Thiophanate-Methyl) |
- |
0 |
|
-- |
| 3.6(Thiamethoxam) |
- |
0 |
|
-- |
| 3.6(Triacontanol) |
- |
0 |
|
-- |
| 3.6(Triadimefon) |
- |
0 |
|
-- |
| 3.6(Trichlorfon) |
- |
0 |
|
-- |
| 3.6(Ampicillin) |
- |
0 |
|
-- |
| 3.6(Apramycin) |
- |
0 |
|
-- |
| 3.6(Albendazole) |
- |
0 |
|
-- |
| 3.6(Chlotetracycline/Oxytetracycline/Tetracycline) |
- |
0 |
|
-- |
| 3.6(Ceftiofur) |
- |
0 |
|
-- |
| 3.6(Cefphactril) |
- |
0 |
|
-- |
| 3.6(Diminazene) |
- |
0 |
|
-- |
| 3.6(Flunixin) |
- |
0 |
|
-- |
| 3.6(Febantel/Fenbendazole/Oxyfendazole) |
- |
0 |
|
-- |
| 3.6(Ivermectin) |
- |
0 |
|
-- |
| 3.6(Lincomycin) |
- |
0 |
|
-- |
| 3.6(Monensin) |
- |
0 |
|
-- |
| 3.6(Meloxicam) |
- |
0 |
|
-- |
| 3.6(Neomycin) |
- |
0 |
|
-- |
| 3.6(Oxyclozanide) |
- |
0 |
|
-- |
| 3.6(Parbendazole) |
- |
0 |
|
-- |
| 3.6(Praziquantel) |
- |
0 |
|
-- |
| 3.6(Spectinomycin) |
- |
0 |
|
-- |
| 3.6(Sulfadiazine) |
- |
0 |
|
-- |
| 3.6(Sulfanilamide) |
- |
0 |
|
-- |
| 3.6(Sulfaquinoxaline) |
- |
0 |
|
-- |
| 3.6(Sulfadimidine) |
- |
0 |
|
-- |
| 3.6(Sulfa Chloropyrazine) |
- |
0 |
|
-- |
| 3.6(Thiabendazole) |
- |
0 |
|
-- |
| 3.6(Trimethoprim) |
- |
0 |
|
-- |
| 3.6(Tylosin) |
- |
0 |
|
-- |
| 3.6(Virginiamycin) |
- |
0 |
|
-- |
| 3.6(Doramectin) |
- |
0 |
|
-- |
|
15 Mar, 2027 |
-
- |
| 9745 |
Bee Pharmo Labs Pvt. Ltd., Thane
| 7139416
| IS 13334 : Part 2 (2014) |
Skimmed milk powder - Specification: Part 2 extra grade (First Revision) |
- |
13000 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| Table 1 (xv)(Listeria monocytogenes (IS 14988 - Part 2 : 2001)) |
- |
400 |
|
-- |
| Table 1 (xiv)(b)(Spore Count: b) Anaerobic (Sulfite reducing Clostridia) Type M (ISO 15213 : 2003)) |
- |
400 |
|
-- |
| Table 1 (xiv)(b)(Spore Count: b) Anaerobic (Sulfite reducing Clostridia) Type m (ISO 15213 : 2003)) |
- |
400 |
|
-- |
| Table 1 (xiv)(a)(Spore Count: a) Aerobic (Bacillus cereus) Type M (IS 5887 - Part 6)) |
- |
400 |
|
-- |
| Table 1 (xiv)(a)(Spore Count: a)Aerobic (Bacillus cereus) Type m (IS 5887 - Part 6)) |
- |
400 |
|
-- |
| Table 1 (xiii)(Salmonella (IS 5887 - Part 3)) |
- |
400 |
|
-- |
| Table 1 (xii)(Coagulase positive Staphylococcus aureus (IS 5887 - Part 2)) |
- |
400 |
|
-- |
| Table 1 (xi)(Escherichia coli (IS 5887 - Part 1)) |
- |
400 |
|
-- |
| Table 1 (x)(Coliform count (IS 5401 - Part 1)) |
- |
400 |
|
-- |
| Table 1 (ix)(Bacterial count (IS 5402)) |
- |
400 |
|
-- |
| Table 1 (viii)(Scorched particles (equivalent to Disc B) (IS 13500)) |
- |
300 |
|
-- |
| Table 1 (vii)(Lactate content (IS 11202)) |
- |
400 |
|
-- |
| Table 1 (vi)(Titratable acidity (IS 11766)) |
- |
300 |
|
-- |
| Table 1 (v)(Total ash (on dry basis), Annex B of IS 14433) |
- |
350 |
|
-- |
| Table 1 (iv)(Insolubility index (IS 12759)) |
- |
300 |
|
-- |
| Table 1 (iii)(Milk fat (IS 117213) or Annex B) |
- |
300 |
|
-- |
| Table 1 (ii)(Milk protein in milk solids not fat (IS 72192)) |
- |
300 |
|
-- |
| Table 1 (i)(Moisture (IS 116231or 16072)) |
- |
300 |
|
-- |
| Clause no 5.4(Flavour) |
- |
0 |
|
- |
| Clause no 5.2(freedom from extraneous matter) |
- |
50 |
|
- |
| Clause no 4(Description) |
- |
50 |
|
- |
| 5.3(orthophosphoric acid and polyphosphoric acid () |
- |
100 |
|
- |
| 5.1(freedom from preservatives, neutralizers and adulterants) |
- |
500 |
|
- |
| 5.8(Pesticides, Heavy metals, toxins & contaminants) |
- |
6550 |
|
- |
|
15 Mar, 2027 |
-
- |
| 9746 |
Bee Pharmo Labs Pvt. Ltd., Thane
| 7139416
| IS 13334 : Part 1 (2014) |
Skimmed milk powder - Specification: Part 1 standard grade (Second Revision) |
Standard grade Spray dried skimmed milk powder |
13500 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| Cl 5.1(Milk intended (IS 1479 - Part 1)) |
- |
400 |
|
- |
| Cl 5.3(Calcium chloride,
citric acid and sodium citrate, sodium salts of
orthophosphoric acid and polyphosphoric acid (as
linear phosphate), ) |
- |
100 |
|
- |
| Cl 5.4(The flavour of the product or of the reconstituted
milk shall be pleasant and clean (see IS 10030).) |
- |
0 |
|
- |
| 4(Description) |
- |
100 |
|
- |
| 5.2(Absence of extraneous matter, added colour and added flavour) |
- |
50 |
|
- |
| 5.6(Moisture) |
- |
300 |
|
- |
| 5.6(Milk protein in milk solids not fat) |
- |
300 |
|
- |
| 5.6(Milk fat) |
- |
300 |
|
- |
| 5.6(Insolubility index) |
- |
300 |
|
- |
| 5.6(Total ash (on dry basis)) |
- |
350 |
|
- |
| 5.6(Titratable acidity (lactic acid)) |
- |
300 |
|
- |
| 5.6(Scorched particles) |
- |
300 |
|
- |
| 5.6(Bacterial count) |
- |
400 |
|
- |
| 5.6(Coliform count ) |
- |
400 |
|
- |
| 5.6(Escherichia coli) |
- |
400 |
|
- |
| 5.6(Coagulase positive Staphylococcus aureus) |
- |
400 |
|
- |
| 5.6(Salmonella) |
- |
400 |
|
- |
| 5.6(Spore count, Aerobic (Bacillus cereus)) |
- |
400 |
|
- |
| 5.6(Spore count, Anaerobic (Sulfite reducing Clostridia)) |
- |
400 |
|
- |
| 5.6(Listeria monocytogenes) |
- |
400 |
|
- |
| 5.7(Pesticides, Heavy metals, toxins & contaminants) |
- |
7500 |
|
- |
|
15 Mar, 2027 |
-
- |
| 9747 |
Bee Pharmo Labs Pvt. Ltd., Thane
| 7139416
| IS 14542 (1998) |
Partly skimmed milk powder specification |
Type I & Type II Spray dried partly skimmed milk powde |
2550 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| Cl 6.6.2(Coliform Count ((IS 5402)) |
- |
400 |
|
-- |
| Cl 6.6.1(Bacterial Count (IS 5402)) |
- |
400 |
|
-- |
| Cl 6.4(Flavour and Taste (IS 10030)) |
- |
150 |
|
-- |
| Table 1(vi)(Titratable acidity (as lactic acid) Type II (IS 11766)) |
- |
200 |
|
-- |
| Table 1(vi)(Titratable acidity (as lactic acid) Type I (IS 11766)) |
- |
0.0 |
|
-- |
| Table 1(v)(Total ash Type II (Annex B of IS 14433 - Part 1)) |
- |
300 |
|
-- |
| Table 1(v)(Total ash Type I (Annex B of IS 14433 - Part 1)) |
- |
0.0 |
|
-- |
| Table 1(iv)(Insolubility index, b) Spray dried Type II (IS 12759)) |
- |
300 |
|
-- |
| Table 1(iv)(Insolubility index, b) Spray dried Type I (IS 12759)) |
- |
0.0 |
|
-- |
| Table 1(iv)(Insolubility index, a) Roller dried Type II (IS 12759)) |
- |
0.0 |
|
-- |
| Table 1(iv)(Insolubility index, a) Roller dried Type I (IS 12759)) |
- |
0.0 |
|
-- |
| Table 1(iii)(Milk fat, Type II (IS I1722)) |
- |
300 |
|
-- |
| Table 1(iii)(Milk fat, Type I (IS I1722)) |
- |
0.0 |
|
-- |
| Table 1(ii)(Total solids (milk solids and added salts) Type II (IS 11623)) |
- |
200 |
|
-- |
| Table 1(ii)(Total solids (milk solids and added salts) Type I (IS 11623)) |
- |
0.0 |
|
-- |
| Table 1(i)(Moisture Type II (IS 11623)) |
- |
300 |
|
-- |
| Table 1(i)(Moisture Type I (IS 11623)) |
- |
0.0 |
|
-- |
|
15 Mar, 2027 |
-
0.0 |
| 9748 |
Bee Pharmo Labs Pvt. Ltd., Thane
| 7139416
| IS 7224 (2006) |
Iodized salt, vacuum evaporated iodized salt and refined iodized salt - Specification (Second Revision) |
Refined Iodized salt/vacuum evaporated Iodized salt/Iod |
3000 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| Clause 4.2(Particle Size) |
- |
200 |
|
-- |
| Clause 4.3 Table 1(Moisture content) |
- |
200 |
|
-- |
| Clause 4.3 Table 1(water insoluble matter) |
- |
300 |
|
-- |
| Clause 4.3 Table 1(Chloride Content(as Nacl)) |
- |
300 |
|
-- |
| Clause 4.3 Table 1(Matter soluble in water other than sodium chloride) |
- |
200 |
|
-- |
| Clause 4.3 Table 1(Calcium (as Ca)) |
- |
250 |
|
-- |
| Clause 4.3 Table 1(Magnesium (as mg)) |
- |
250 |
|
-- |
| Clause 4.3 Table 1(Sulphate (as SO4 ),) |
- |
300 |
|
-- |
| Clause 4.3 Table 1(Iodine content, a) Manufacturers Level ) |
- |
250 |
|
-- |
| Clause 4.3 Table 1(b) Distribution channel including retailer) |
- |
250 |
|
-- |
| Clause 4.3 Table 1(Alkalinity (as Na2CO3),) |
- |
300 |
|
-- |
| Clause 4.3 Table 1(Lead as (Pb)) |
- |
300 |
|
-- |
| Clause 4.3 Table 1(Arsenic(as As)) |
- |
300 |
|
-- |
| Clause 4.3 Table 1(Iron(as Fe)) |
- |
300 |
|
-- |
|
15 Mar, 2027 |
-
0.0 |
| 9749 |
Bee Pharmo Labs Pvt. Ltd., Thane
| 7139416
| IS 253 (2014) |
Specification for common salt (Fourth Revision) |
- |
3000 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| Clause -3 for common salt 3.1 ( 3.1.1 ) ( The material shall be crystalline solid, white or pale pink or light grey in colour.) |
- |
0.0 |
|
-- |
| Clause -3 for common salt 3.1 ( 3.1.2 ) Annex-2(Moisture The material shall contain not more than 6.0 percent by mass of moisture, on as received basis, when tested according to the method given in A-2) |
- |
250 |
|
-- |
| Clause-3.2 for dairy salt (3.2.1)(The material shall be crystalline white solid and free from any visible impurities.) |
- |
0.0 |
|
-- |
| Clause-3.1 for dairy salt (3.2.2)(3.2.2 Particle Size 99 percent by mass of the material shall pass completely through 850-micron IS Sieve [see IS 460 (Part I)].) |
- |
0.0 |
|
-- |
| Clause-3.2 for dairy salt (3.2.3) Annex -2(3.2.3 Moisture The material shall contain not more than 0.5 percent by mass of moisture, on as received basis, when tested according to the methods given in A-2.) |
- |
250 |
|
-- |
| Table 1 (i) Annex -4(Water insoluble matter, common) |
- |
200 |
|
-- |
| Table 1 (i) Annex -4(Water insoluble matter, Dairy) |
- |
0.0 |
|
-- |
| Table 1 (ii) Annex-5(Chloride content (as NaCl)common) |
- |
250 |
|
-- |
| Table 1 (ii) Annex-5(Chloride content (as NaCl), Dairy) |
- |
0.0 |
|
-- |
| Table 1 (iii) Annex-6( Matter soluble in water, other than sodium chloride, common) |
- |
150 |
|
-- |
| Table 1 (iii) Annex-6( Matter soluble in water, other than sodium chloride, Dairy) |
- |
0.0 |
|
-- |
| Table 1 (iv)(Calcium (as Ca), water soluble, percent by mass, common) |
- |
200 |
|
-- |
| Table 1 (iv) Annex-7(Calcium (as Ca), water soluble, percent by mass, Dairy) |
- |
0.0 |
|
-- |
| Table 1 (v)(Magnesium (as Mg), water soluble, percent by mass, common ) |
- |
200 |
|
-- |
| Table 1 (v) Annex-7(Magnesium (as Mg), water soluble, percent by mass, Dairy ) |
- |
0.0 |
|
-- |
| Table 1 (viii)(Lead (as Pb), common) |
- |
300 |
|
-- |
| Table 1 (viii)(Lead (as Pb),Dairy ) |
- |
0.0 |
|
-- |
| Table 1 (x) Annex-11(x) Arsenic (as As), common) |
- |
300 |
|
-- |
| Table 1 (x) Annex-11(x) Arsenic (as As),Dairy) |
- |
0.0 |
|
-- |
| Table 1 (xi) Annex-12(Copper (as Cu), common) |
- |
300 |
|
-- |
| Table 1 (vi)(Sulphate as SO2 percent by mass, common) |
- |
200 |
|
-- |
| Table 1 (vi) Annex-8(sulphate as SO2 percent by mass, Dairy) |
- |
0.0 |
|
-- |
| Table 1 (vii) Annex-9(Alkalinity (as Na2CO3), common) |
- |
200 |
|
-- |
| Table 1 (vii) Annex-11(Alkalinity (as Na2CO3), Dairy) |
- |
0.0 |
|
-- |
| Table 1 (ix)(Iron (as Fe), common) |
- |
300 |
|
-- |
| Table 1 (ix)(Iron (as Fe), Dairy) |
- |
0.0 |
|
-- |
|
15 Mar, 2027 |
-
0.0 |
| 9750 |
Bee Pharmo Labs Pvt. Ltd., Thane
| 7139416
| IS 1011 (2002) |
Biscuits - Specification (Fourth Revision) |
- |
1550 View breakup
-
| Clause No. |
Exclusion |
Testing Charges (Excl. Of Taxes) |
Effective Date |
Remark |
| 6.1(General Requirement) |
- |
400 |
|
-- |
| 6.3 Table 2 i (Moisture) |
- |
350 |
|
-- |
| 6.3 Table 2 ii (Acid insoluble ash (on dry basis)) |
- |
350 |
|
-- |
| 6.3 Table 2 iii (Acidity of extracted fat (as oleic acid)) |
- |
450 |
|
-- |
|
15 Mar, 2027 |
-
0.0 |
